Prion protein conversions: insight into mechanisms, TSE transmission barriers and strains.

Conversion of PrP(C) to aberrant forms such as PrP(Sc) appears to be critical in the transmission and pathogenesis of transmissible spongiform encephalopathies (TSEs) or prion diseases. In vitro studies have shown that TSE-associated, protease-resistant forms of PrP can cause PrP(C) to convert to forms that are similarly protease-resistant under a wide variety of conditions. These observations have provided evidence that pathological forms of PrP have at least limited capacity to propagate themselves, which is necessary for them to be infectious. PrP conversion reactions have proven to be highly specific and appear to account, at least in part, for TSE species barriers and the propagation of strains. Such in vitro conversion systems have yielded insights into the molecular mechanisms of TSE disease and are being exploited as screens for anti-TSE drugs and as bases for diagnostic tests.

[1]  I. Gilbert,et al.  Screening Congo Red and its analogues for their ability to prevent the formation of PrP-res in scrapie-infected cells. , 2000, The Journal of general virology.

[2]  S. Priola.  Prion protein and species barriers in the transmissible spongiform encephalopathies. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[3]  J. Aiken,et al.  The host range of chronic wasting disease is altered on passage in ferrets. , 1998, Virology.

[4]  B. Caughey,et al.  Interactions between prion protein isoforms: the kiss of death? , 2001, Trends in biochemical sciences.

[5]  B. Caughey,et al.  Congo red inhibition of scrapie agent replication , 1993, Journal of virology.

[6]  J. Collinge,et al.  Transgenic studies of the influence of the PrP structure on TSE diseases. , 2001, Advances in protein chemistry.

[7]  B. Caughey,et al.  Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease‐resistant state , 1999, The EMBO journal.

[8]  G. J. Raymond,et al.  Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells , 1993, Journal of virology.

[9]  B. Roberts,et al.  Yeast prions act as genes composed of self-propagating protein amyloids. , 2001, Advances in protein chemistry.

[10]  M. Smits,et al.  Susceptibility of Sheep for Scrapie as Assessed by In Vitro Conversion of Nine Naturally Occurring Variants of PrP , 2000, Journal of Virology.

[11]  Witold K. Surewicz,et al.  Crystal structure of the human prion protein reveals a mechanism for oligomerization , 2002, Nature Structural Biology.

[12]  B. Caughey,et al.  Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Lindquist,et al.  Chaperone-supervised conversion of prion protein to its protease-resistant form. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[14]  I. Vorberg,et al.  Molecular Basis of Scrapie Strain Glycoform Variation* , 2002, The Journal of Biological Chemistry.

[15]  B. Chesebro,et al.  Species-Independent Inhibition of Abnormal Prion Protein (PrP) Formation by a Peptide Containing a Conserved PrP Sequence , 1999, Journal of Virology.

[16]  H. Scheraga,et al.  A role for intermolecular disulfide bonds in prion diseases? , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  P. Lansbury,et al.  Non-genetic propagation of strain-specific properties of scrapie prion protein , 1995, Nature.

[18]  C. Leucht,et al.  Interaction of prion proteins with cell surface receptors, molecular chaperones, and other molecules. , 2001, Advances in protein chemistry.

[19]  B. Caughey,et al.  The Role of Helix 1 Aspartates and Salt Bridges in the Stability and Conversion of Prion Protein* , 2003, The Journal of Biological Chemistry.

[20]  G. J. Raymond,et al.  The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. , 1991, The Journal of biological chemistry.

[21]  B. Chesebro,et al.  Specific Inhibition of in Vitro Formation of Protease-resistant Prion Protein by Synthetic Peptides* , 1998, The Journal of Biological Chemistry.

[22]  P. Lansbury,et al.  The chemistry of scrapie infection: implications of the 'ice 9' metaphor. , 1995, Chemistry & biology.

[23]  C. Soto,et al.  Cell-lysate conversion of prion protein into its protease-resistant isoform suggests the participation of a cellular chaperone. , 1999, Biochemical and biophysical research communications.

[24]  B. Caughey,et al.  Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  P. Lansbury,et al.  Scrapie infectivity correlates with converting activity, protease resistance, and aggregation of scrapie-associated prion protein in guanidine denaturation studies , 1997, Journal of virology.

[26]  B. Caughey,et al.  Inhibition of Interactions and Interconversions of Prion Protein Isoforms by Peptide Fragments from the C-terminal Folded Domain* , 2001, The Journal of Biological Chemistry.

[27]  D. Harris.  Biosynthesis and cellular processing of the prion protein. , 2001, Advances in protein chemistry.

[28]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[29]  B. Caughey,et al.  Prion protein interconversions and the transmissible spongiform encephalopathies. , 1999, Structure.

[30]  I. Izquierdo,et al.  Cellular prion protein binds laminin and mediates neuritogenesis. , 2000, Brain research. Molecular brain research.

[31]  B. Caughey,et al.  Reversibility of Scrapie-associated Prion Protein Aggregation* , 2001, The Journal of Biological Chemistry.

[32]  K. Winklhofer,et al.  Cationic Lipopolyamines Induce Degradation of PrPSc in Scrapie-Infected Mouse Neuroblastoma Cells , 2000, Biological chemistry.

[33]  B. Caughey,et al.  Potent Inhibition of Scrapie‐Associated PrP Accumulation by Congo Red , 1992, Journal of neurochemistry.

[34]  J. Collinge,et al.  Protease-resistant prion protein produced in vitro lacks detectable infectivity. , 1999, The Journal of general virology.

[35]  P. Lansbury,et al.  Cell-free formation of protease-resistant prion protein , 1994, Nature.

[36]  G. J. Raymond,et al.  Interactions and conversions of prion protein isoforms. , 2001, Advances in protein chemistry.

[37]  J. Collinge,et al.  Strain-specific prion-protein conformation determined by metal ions , 1999, Nature Cell Biology.

[38]  G. J. Raymond,et al.  In Situ Formation of Protease-resistant Prion Protein in Transmissible Spongiform Encephalopathy-infected Brain Slices* , 1997, The Journal of Biological Chemistry.

[39]  F. Cohen,et al.  Elimination of prions by branched polyamines and implications for therapeutics. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[40]  C. Bostock,et al.  Characterization and polyanion-binding properties of purified recombinant prion protein. , 1999, The Biochemical journal.

[41]  P. Lansbury,et al.  Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.

[42]  S. Lindquist,et al.  The yeast prion [PSI+]: molecular insights and functional consequences. , 2001, Advances in protein chemistry.

[43]  P. McBride,et al.  Precise targeting of the pathology of the sialoglycoprotein, PrP, and vacuolar degeneration in mouse scrapie , 1989, Neuroscience Letters.

[44]  B. Chesebro,et al.  Sulfated glycans and elevated temperature stimulate PrPSc‐dependent cell‐free formation of protease‐resistant prion protein , 2001, The EMBO journal.

[45]  B. Caughey,et al.  Lysosomotropic Agents and Cysteine Protease Inhibitors Inhibit Scrapie-Associated Prion Protein Accumulation , 2000, Journal of virology.

[46]  F. Hartl,et al.  A sensitive filter retention assay for the detection of PrPSc and the screening of anti‐prion compounds , 2001 .

[47]  V. Daggett,et al.  Simulations and computational analyses of prion protein conformations. , 2001, Advances in protein chemistry.

[48]  G. J. Raymond,et al.  Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease , 2000, The EMBO journal.

[49]  Suzette Apriola.  Prion protein diversity and disease in the transmissible spongiform encephalopathies , 2001 .

[50]  P. Lansbury,et al.  Molecular assessment of the potential transmissibilities of BSE and scrapie to humans , 1997, Nature.

[51]  P. Lansbury,et al.  Aggregates of scrapie-associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state. , 1995, Chemistry & biology.

[52]  B. Chesebro,et al.  Structural Aspects of Congo Red as an Inhibitor of Protease‐Resistant Prion Protein Formation , 1998, Journal of neurochemistry.

[53]  S. Prusiner,et al.  Expression of unglycosylated mutated prion protein facilitates PrP(Sc) formation in neuroblastoma cells infected with different prion strains. , 2000, The Journal of general virology.

[54]  B. Caughey,et al.  Effect of Glycosylphosphatidylinositol Anchor-dependent and -independent Prion Protein Association with Model Raft Membranes on Conversion to the Protease-resistant Isoform* , 2003, The Journal of Biological Chemistry.

[55]  B. Permanne,et al.  Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding , 2001, Nature.

[56]  B. Chesebro,et al.  Conversion of raft associated prion protein to the protease‐resistant state requires insertion of PrP‐res (PrPSc) into contiguous membranes , 2002, The EMBO journal.

[57]  H. Scheraga,et al.  Intramolecular Versus Intermolecular Disulfide Bonds in Prion Proteins* , 2002, The Journal of Biological Chemistry.

[58]  R. Glockshuber.  Folding dynamics and energetics of recombinant prion proteins. , 2001, Advances in protein chemistry.

[59]  E I Shakhnovich,et al.  Evidence for the role of PrP(C) helix 1 in the hydrophilic seeding of prion aggregates. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[60]  E. Williams,et al.  EPIZOOTIOLOGY OF CHRONIC WASTING DISEASE IN FREE-RANGING CERVIDS IN COLORADO AND WYOMING , 2000, Journal of wildlife diseases.

[61]  F. Cohen,et al.  Mimicking dominant negative inhibition of prion replication through structure-based drug design. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[62]  David A Agard,et al.  Structural studies of the scrapie prion protein by electron crystallography , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[63]  S. Prusiner,et al.  Chimeric prion protein expression in cultured cells and transgenic mice , 1992, Protein science : a publication of the Protein Society.